Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Wednesday 28 March, 2012

AstraZeneca PLC

Director/PDMR Shareholding

RNS Number : 2799A
AstraZeneca PLC
28 March 2012
 



Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

The interest of David Brennan, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below. 

 

On 27 March 2012, Mr Brennan received shares from the vesting of a previously announced award made in March 2009 under the AstraZeneca Performance Share Plan (AZPSP) whereby, following the application of performance measures specified at the time of grant, he has now become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

 

 

Name

Shares awarded

Shares vested

Shares withheld

Net shares received

Market price on vesting

 

David R Brennan

 

133,347

 

104,010

 

54,439

 

49,571

 

2854p

 

Mr Brennan has interests in both the ordinary shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one ordinary share.

 

As a result of this transaction, Mr Brennan has an interest in 578,733 ordinary shares and 83,344 AstraZeneca ADSs, which together represent approximately 0.05% of the Company's issued ordinary capital.

 

A C N Kemp

Company Secretary

28 March 2012


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUWUORUSAOUAR

a d v e r t i s e m e n t